Sharon Fekrat

Associate Professor of Ophthalmology
Associate Professor in the Department of Surgery
Campus mail: DUMC 3802, Durham, NC 27710
Phone: (919) 684-1857

Dr. Fekrat specializes in adult vitreoretinal diseases, with particular expertise in retinal vein occlusion. Fekrat has co-authored over 100 publications in peer-reviewed medical journals and over 40 textbook chapters. She has co-authored two and co-edited four books including Duke Eye Center’s All About Your Eyes. She has held various leadership roles at the Durham Veterans Affairs Medical Center including Chief of Ophthalmology, Acting Chief of Surgery, Acting Deputy Chief of Staff, and is currently Associate Chief of Staff. Fekrat sits on the Editorial Board of the American Journal of Ophthalmology, Retinal Physician, Ophthalmology Times, Ophthalmic Surgery Lasers Imaging Retina, Retina Times, and the American Academy of Ophthalmology’s (AAO) EyeNet. She has received the Senior Achievement Award from the AAO. She has been selected by her peers to Best Doctors in Business North Carolina annually since 2005. Fekrat was selected as one of 150 retina doctors leading retinal innovation by Ocular Surgery News. She is Director of the Vitreoretinal Surgery Fellowship Program and Director of Ophthalmology Faculty Career Development. Dr. Fekrat is Past President of the North Carolina Society of Eye Physicians and Surgeons. 

Education and Training

  • Oxford University (U.K.), C. 1985
  • Georgetown University, B.S. 1987
  • University of Chicago, M.D. 1991

Publications

CENTRAL RETINAL VEIN OCCLUSION IN GATA2 DEFICIENCY.

To examine the association between GATA2 deficiency-related myelodysplastic syndrome (MDS) and central retinal vein occlusion (CRVO).Clinical ophthalmologic examination and laboratory work-up was performed for a patient with GATA2 deficiency-relat

Dynamic Imaging of a Pigmented Free-Floating Vitreous Cyst.

The authors present an incidentally noted pigmented anterior vitreous cyst in an asymptomatic male adult. Observation was elected. Stability during the course of 2 years and mobility of the vitreous cyst using dynamic imaging are demonstrated.

Pages